Search

Your search keyword '"Hand, Foot and Mouth Disease"' showing total 835 results

Search Constraints

Start Over You searched for: Descriptor "Hand, Foot and Mouth Disease" Remove constraint Descriptor: "Hand, Foot and Mouth Disease" Topic enterovirus Remove constraint Topic: enterovirus
835 results on '"Hand, Foot and Mouth Disease"'

Search Results

1. Effectiveness of enterovirus A71 vaccine against pediatric HFMD and disease profile of post-vaccination infection.

2. Age-time-specific transmission of hand-foot-and-mouth disease enterovirus serotypes in Vietnam: A catalytic model with maternal immunity.

3. Cordycepin Inhibits Enterovirus A71 Replication and Protects Host Cell from Virus-Induced Cytotoxicity through Adenosine Action Pathway.

4. Advances in anti-EV-A71 drug development research.

5. Enterovirus 71 leads to abnormal mitochondrial dynamics in human neuroblastoma SK-N-SH cells.

6. Antiviral activity of SP81 peptide against Enterovirus A71 (EV-A71).

7. Establishment of the 1st Chinese national standard for CA6 neutralizing antibody.

8. The stability and immunogenicity of formalin-inactivated Enterovirus A71 whole virion vaccine after ten years of low temperature storage.

9. Dual carminic acid/hemin-marked DNA probes for simultaneously detecting CV-A16 and EV-A71 based on the mechanism of dimer to monomer transition.

10. Proteomic and phosphoproteomic analysis of responses to enterovirus A71 infection reveals novel targets for antiviral and viral replication.

11. Coxsackievirus A6 pneumonia in a child.

12. An enterovirus A71 virus-like particle with replaced loops confers partial cross-protection in mice.

13. The Upf1 protein restricts EV-A71 viral replication.

14. Neutralization of African enterovirus A71 genogroups by antibodies to canonical genogroups.

15. Epidemiology of hand, foot and mouth disease and genomic surveillance of coxsackievirus A10 circulating in Zhejiang Province, China during 2017 to 2022.

16. HMGB1 is involved in viral replication and the inflammatory response in coxsackievirus A16-infected 16HBE cells via proteomic analysis and identification.

17. Structure-based virtual screening of ROCK1 inhibitors for the discovery of Enterovirus-A71 antivirals.

18. SHFL inhibits enterovirus A71 infection by triggering degradation of viral 3D pol protein via the ubiquitin-proteasome pathway.

19. Effect of proteins isolated from Brazilian snakes on enterovirus A71 replication cycle: An approach against hand, foot and mouth disease.

20. Antibody signatures in hospitalized hand, foot and mouth disease patients with acute enterovirus A71 infection.

21. The internal ribosome entry site determines the neurotropic potential of enterovirus A71.

22. Targeting HDAC11 activity by FT895 restricts EV71 replication.

23. Global quantitative proteomic analysis profiles of host protein expression in response to enterovirus A71 infection in bronchial epithelial cells based on tandem mass tag (TMT) peptide labeling coupled with LC-MS/MS uncovers the key role of proteasome in virus replication.

24. Identification of a novel acylthiourea-based potent broad-spectrum inhibitor for enterovirus 3D polymerase in vitro and in vivo.

25. Identification of a Conserved, Linear Epitope on VP3 of Enterovirus A Species Recognized by a Broad-Spectrum Monoclonal Antibody.

26. Identification of specific and shared epitopes at the extreme N-terminal VP1 of Coxsackievirus A4, A2 and A5 by monoclonal antibodies.

27. Human SCARB2 Acts as a Cellular Associator for Helping Coxsackieviruses A10 Infection.

28. PLX8394, a RAF inhibitor, inhibits enterovirus 71 replication by blocking RAF/MEK/ERK signaling.

29. Diagnostic performance of different specimens in detecting enterovirus A71 in children with hand, foot and mouth disease.

30. Factors related to the mortality risk of severe hand, foot, and mouth diseases (HFMD): a 5-year hospital-based survey in Guangxi, Southern China.

31. Long-term sentinel surveillance of enteroviruses in Gwangju, South Korea, 2011-2020.

32. Vertical Transmission of Coxsackievirus A6 with Severe Congenital Pneumonia/Sepsis.

33. Local immune dysregulation and subsequent inflammatory response contribute to pulmonary edema caused by Enterovirus infection in mice.

34. Clinical profile and molecular typing of viral etiological agents associated with Hand, Foot and Mouth Disease (HFMD): A study from Udhampur, Northern India.

35. Proteomic and metabonomic analysis uncovering Enterovirus A71 reprogramming host cell metabolic pathway.

36. A mouse-adapted CVA6 strain exhibits neurotropism and triggers systemic manifestations in a novel murine model.

37. Rock1 is a novel host dependency factor of human enterovirus A71: Implication as a drug target.

38. The Bottlenecks of Preparing Virus Particles by Size Exclusion for Antibody Generation.

39. Activation of Host Cellular Signaling and Mechanism of Enterovirus 71 Viral Proteins Associated with Hand, Foot and Mouth Disease.

40. Urolithin A inhibits enterovirus 71 replication and promotes autophagy and apoptosis of infected cells in vitro.

42. Introduction and Differential Diagnosis of Monkeypox in Argentina, 2022.

43. The impact of enterovirus A71 vaccination program on hand, foot, and mouth disease in Guangdong, China: A longitudinal surveillance study.

44. Cryo-electron microscopy and image classification reveal the existence and structure of the coxsackievirus A6 virion.

45. The secular trend of enterovirus A71 after the implementation of preventive measures in Taiwan.

46. In-vitro antiviral activity of doxepin hydrochloride against group B coxsackievirus.

47. Does enterovirus 71 urge for effective vaccine control strategies? Challenges and current opinion.

48. Characterization of G-Quadruplexes in Enterovirus A71 Genome and Their Interaction with G-Quadruplex Ligands.

49. Hand, foot, and mouth disease in adults caused by Coxsackievirus B1-B6.

50. Type I Interferon-Induced TMEM106A Blocks Attachment of EV-A71 Virus by Interacting With the Membrane Protein SCARB2.

Catalog

Books, media, physical & digital resources